美股A股
StockGist
Back
8-K2026-03-12· grok-4-1-fast-non-reasoning

DNTH · Dianthus Therapeutics, Inc.

0001193125-26-103053

SEC filing

Summary

Dianthus Therapeutics, Inc. entered into an underwriting agreement on March 10, 2026, constituting a material definitive agreement. The filing includes the underwriting agreement as Exhibit 1.1.

Key takeaways